Enovis CORP (ENOV) SEC Filings

Enovis CORP (ENOV) reported that Chief Administrative Officer Oliver Engert purchased common stock in the open market. On September 4, 2026, he bought 2,660 shares of common stock at a weighted average price of $18.80 per share, in multiple trades between $18.74 and $18.85. Following this transaction, he directly holds 63,898 shares of Enovis common stock.

Enovis CORP (ENOV) reported that Chief Administrative Officer Oliver Engert purchased a total of 7,598 shares of Enovis common stock in open market or private transactions on September 2 and 3, 2026. The reported weighted average prices were $20.32 and $19.46 per share, based on multiple trades within disclosed price ranges, and no Rule 10b5-1 trading plan is reported.

Enovis CORP (ENOV) reported that Chief Executive Officer and director Damien McDonald purchased 13,035 shares of common stock on September 4, 2026 in an open-market transaction at a weighted average price of $19.15 per share, with individual trade prices ranging from $19.10 to $19.16. Following this purchase, he directly holds 247,077 shares of Enovis common stock. No Rule 10b5-1 trading plan is reported for this transaction.

Enovis Corporation (ENOV) announced a binding offer to acquire eCential Robotics SAS, a developer of enabling technologies and surgical robotics, to expand its ASTRA™ technology platform and robotics capabilities. The deal values eCential at an enterprise value of €155 million, with upfront cash consideration of €176 million to be paid to eCential shareholders at closing.

The agreement also includes up to €35 million in additional contingent cash consideration tied to milestone achievements. Enovis plans to fund the transaction with cash on hand and availability under its existing revolving credit facility. Closing is expected by year-end 2026, subject to regulatory approvals and French works council consultation.

Enovis expects the acquisition to cause approximately 150 basis points of deal-related dilution to Adjusted EBITDA margin in 2027, partially offset by about 50 basis points of underlying margin improvement, resulting in a net 100 basis point headwind in 2027. Free cash flow conversion is expected to rise to 50% in 2027, to over $100 million, with further improvement anticipated in 2028 and 2029.

Enovis Corporation’s common stock is the subject of a Schedule 13G filed by Rubric Capital Management LP and David Rosen, who together report beneficial ownership of 3,900,000 shares of Enovis common stock. This represents 6.78% of the class, based on 57,562,603 shares outstanding as of May 1, 2026, as reported by Enovis. The shares are held by certain investment funds and/or accounts advised by Rubric Capital, including Rubric Capital Master Fund LP, which has the right to receive dividends and sale proceeds on more than 5% of the outstanding shares.

Both Rubric Capital and David Rosen report shared voting power and shared dispositive power over the 3,900,000 shares, with no sole voting or dispositive power. The filing states that it should not be construed as an admission that any reporting person is a beneficial owner of the reported shares for purposes of Section 13 of the Exchange Act.

Enovis Corporation reported higher sales and returned to operating profitability for the three and six months ended July 3, 2026. Net sales were $582,782 (Dollars in thousands) for the quarter and $1,171,933 (Dollars in thousands) year to date, up from $564,545 and $1,123,379 (Dollars in thousands) a year earlier. Operating income reached $17,413 (Dollars in thousands) for the quarter and $23,943 (Dollars in thousands) year to date, compared with operating losses in the prior periods. Higher income tax expense produced small net losses attributable to Enovis of $1,190 and $9,954 (Dollars in thousands), versus $36,739 and $92,705 (Dollars in thousands).

Prevention & Recovery revenue was broadly flat, while Reconstructive grew in both U.S. and international markets. Total Adjusted EBITDA rose to $104,321 and $207,888 (Dollars in thousands), with margins of 17.9% and 17.7%. Currency movements increased net sales by 1.0% for the quarter and 2.6% year to date. The effective tax rate exceeded 21% due to valuation allowances on U.S. deferred tax assets, non‑deductible expenses and U.S. taxation of international operations.

Operating activities generated $98,983 (Dollars in thousands) of cash in the first half, largely funding capital expenditures of $96,699 (Dollars in thousands). Cash and cash equivalents were $12,563 (Dollars in thousands), with total debt of $1,284,508 (In thousands), including a $670,559 term loan and $453,407 (In thousands) of senior unsecured convertible notes; $942 million remained available under the revolving credit facility. The company was in compliance with its credit agreement covenants and uses cross‑currency swaps and forward contracts to manage foreign exchange exposure.

Enovis Corporation reported second-quarter 2026 net sales of $582.8 million, up from $564.5 million a year earlier, driven by 7.5% reported growth in Reconstructive while Prevention & Recovery was roughly flat on a reported basis but grew 3.5% organically.

The company posted a small GAAP net loss of $1.0 million (0.2% of sales), but generated adjusted net income of $52.2 million and adjusted diluted EPS of $0.90. Adjusted EBITDA rose to $104.3 million, a 17.9% margin, compared with $91.2 million and a 16.2% margin in the prior-year quarter.

For 2026, Enovis reaffirmed guidance for revenue of $2.31–$2.37 billion with 4–6% organic growth, adjusted EBITDA of $425–$435 million, adjusted EPS of $3.52–$3.73, and free cash flow conversion of at least 25%.

BlackRock, Inc. has filed an amended Schedule 13G reporting its beneficial ownership of common stock of Enovis Corporation. BlackRock reports beneficial ownership of 9,181,052 shares of Enovis common stock, representing 15.9% of the class.

BlackRock has sole voting power over 9,087,287 shares and sole dispositive power over 9,181,052 shares, with no shared voting or dispositive power. The filing notes that this reflects securities beneficially owned, or deemed beneficially owned, by certain BlackRock business units. It also states that iShares Core S&P Small-Cap ETF has an interest in Enovis common stock representing more than five percent of the total outstanding common stock.

Enovis Corporation Schedule 13G/A amendment discloses beneficial ownership positions held by American Century entities and Stowers Institute. The filing lists American Century Investment Management, Inc. and American Century Companies, Inc. each holding 6,106,561 shares (10.6%), and American Century Capital Portfolios, Inc. holding 2,689,128 shares (4.7%), as reported on the cover pages. The registrants state their principal business address and identify voting and dispositive powers for each holder. The filing is an ownership disclosure amendment signed on 07/08/2026.